ESR1 and breast carcinoma: We found evidence of four loci potentially associated with breast cancer survival: one in the subgroup of patients diagnosed with a grade 3 tumor, one in the subgroup of patients with an ER+ tumor and treated with endocrine therapy, and two in the subgroup of patients with an ER− tumor and treated with chemotherapy.